Global Pediatric Epilepsy Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Epilepsy is one of the most common and challenging neurologic disorders affecting children.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Pediatric Epilepsy Therapeutics estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

Pediatric epilepsies present particular challenges, including correct diagnoses, comorbidities and interactions with developmental processes in the brain.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pediatric Epilepsy Therapeutics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Pediatric Epilepsy Therapeutics market. Further, it explains the major drivers and regional dynamics of the global Pediatric Epilepsy Therapeutics market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Abbott Laboratories

GlaxoSmithKline

Cephalon

Pfizer

Novartis

Sunovion Pharmaceuticals

Bausch Health

Sanofi

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Benign Rolandic Epilepsy

Childhood Absence Epilepsy

Juvenile Myoclonic Epilepsy

Infantile Spasms

Lennox-Gastaut Syndrome

Hospitals

Neurology Centers

Home Care Settings

Ambulatory Surgical Centers

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Pediatric Epilepsy Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Pediatric Epilepsy Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Pediatric Epilepsy Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pediatric Epilepsy Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediatric Epilepsy Therapeutics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Pediatric Epilepsy Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Pediatric Epilepsy Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott Laboratories, GlaxoSmithKline, Cephalon, Pfizer, Novartis, Sunovion Pharmaceuticals, Bausch Health and Sanofi, etc.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pediatric Epilepsy Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Benign Rolandic Epilepsy

1.2.3 Childhood Absence Epilepsy

1.2.4 Juvenile Myoclonic Epilepsy

1.2.5 Infantile Spasms

1.2.6 Lennox-Gastaut Syndrome

1.3 Market by Application

1.3.1 Global Pediatric Epilepsy Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Neurology Centers

1.3.4 Home Care Settings

1.3.5 Ambulatory Surgical Centers

1.4 Study Objectives

1.5 Years Considered

2.1 Global Pediatric Epilepsy Therapeutics Market Size (2017-2028)

2.2 Pediatric Epilepsy Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Pediatric Epilepsy Therapeutics Market Size by Region (2017-2022)

2.4 Global Pediatric Epilepsy Therapeutics Market Size Forecast by Region (2023-2028)

2.5 Global Top Pediatric Epilepsy Therapeutics Countries Ranking by Market Size

3.1 Global Pediatric Epilepsy Therapeutics Revenue by Players

3.1.1 Global Pediatric Epilepsy Therapeutics Revenue by Players (2017-2022)

3.1.2 Global Pediatric Epilepsy Therapeutics Market Share by Players (2017-2022)

3.2 Global Pediatric Epilepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Pediatric Epilepsy Therapeutics Revenue

3.4 Global Pediatric Epilepsy Therapeutics Market Concentration Ratio

3.4.1 Global Pediatric Epilepsy Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pediatric Epilepsy Therapeutics Revenue in 2021

3.5 Global Pediatric Epilepsy Therapeutics Key Players Head office and Area Served

3.6 Key Players Pediatric Epilepsy Therapeutics Product Solution and Service

3.7 Date of Enter into Pediatric Epilepsy Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pediatric Epilepsy Therapeutics Historic Revenue by Type (2017-2022)

4.2 Global Pediatric Epilepsy Therapeutics Forecasted Revenue by Type (2023-2028)

5.1 Global Pediatric Epilepsy Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Application (2023-2028)

6.1 North America Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022)

6.2 North America Pediatric Epilepsy Therapeutics Revenue by Type (2017-2028)

6.3 North America Pediatric Epilepsy Therapeutics Revenue by Application (2017-2028)

6.4 North America Pediatric Epilepsy Therapeutics Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7.1 Europe Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022)

7.2 Europe Pediatric Epilepsy Therapeutics Revenue by Type (2017-2028)

7.3 Europe Pediatric Epilepsy Therapeutics Revenue by Application (2017-2028)

7.4 Europe Pediatric Epilepsy Therapeutics Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8.1 Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022)

8.2 Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Type (2017-2028)

8.3 Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Application (2017-2028)

8.4 Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9.1 Latin America Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022)

9.2 Latin America Pediatric Epilepsy Therapeutics Revenue by Type (2017-2028)

9.3 Latin America Pediatric Epilepsy Therapeutics Revenue by Application (2017-2028)

9.4 Latin America Pediatric Epilepsy Therapeutics Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10.1 Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022)

10.2 Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Type (2017-2028)

10.3 Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Application (2017-2028)

10.4 Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 U.A.E

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Pediatric Epilepsy Therapeutics Products and Services

11.1.4 Abbott Laboratories Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)

11.1.5 Abbott Laboratories Pediatric Epilepsy Therapeutics SWOT Analysis

11.1.6 Abbott Laboratories Recent Developments

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Details

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Pediatric Epilepsy Therapeutics Products and Services

11.2.4 GlaxoSmithKline Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)

11.2.5 GlaxoSmithKline Pediatric Epilepsy Therapeutics SWOT Analysis

11.2.6 GlaxoSmithKline Recent Developments

11.3 Cephalon

11.3.1 Cephalon Company Details

11.3.2 Cephalon Business Overview

11.3.3 Cephalon Pediatric Epilepsy Therapeutics Products and Services

11.3.4 Cephalon Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)

11.3.5 Cephalon Pediatric Epilepsy Therapeutics SWOT Analysis

11.3.6 Cephalon Recent Developments

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Pediatric Epilepsy Therapeutics Products and Services

11.4.4 Pfizer Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)

11.4.5 Pfizer Pediatric Epilepsy Therapeutics SWOT Analysis

11.4.6 Pfizer Recent Developments

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Pediatric Epilepsy Therapeutics Products and Services

11.5.4 Novartis Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)

11.5.5 Novartis Pediatric Epilepsy Therapeutics SWOT Analysis

11.5.6 Novartis Recent Developments

11.6 Sunovion Pharmaceuticals

11.6.1 Sunovion Pharmaceuticals Company Details

11.6.2 Sunovion Pharmaceuticals Business Overview

11.6.3 Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Products and Services

11.6.4 Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)

11.6.5 Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics SWOT Analysis

11.6.6 Sunovion Pharmaceuticals Recent Developments

11.7 Bausch Health

11.7.1 Bausch Health Company Details

11.7.2 Bausch Health Business Overview

11.7.3 Bausch Health Pediatric Epilepsy Therapeutics Products and Services

11.7.4 Bausch Health Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)

11.7.5 Bausch Health Pediatric Epilepsy Therapeutics SWOT Analysis

11.7.6 Bausch Health Recent Developments

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Pediatric Epilepsy Therapeutics Products and Services

11.8.4 Sanofi Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022)

11.8.5 Sanofi Pediatric Epilepsy Therapeutics SWOT Analysis

11.8.6 Sanofi Recent Developments

12.1 Pediatric Epilepsy Therapeutics Market Trends

12.2 Pediatric Epilepsy Therapeutics Market Drivers

12.3 Pediatric Epilepsy Therapeutics Market Challenges

12.4 Pediatric Epilepsy Therapeutics Market Restraints

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

List of Tables

    Table 1. Global Pediatric Epilepsy Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Benign Rolandic Epilepsy

    Table 3. Key Players of Childhood Absence Epilepsy

    Table 4. Key Players of Juvenile Myoclonic Epilepsy

    Table 5. Key Players of Infantile Spasms

    Table 6. Key Players of Lennox-Gastaut Syndrome

    Table 7. Global Pediatric Epilepsy Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 8. Global Pediatric Epilepsy Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

    Table 9. Global Pediatric Epilepsy Therapeutics Revenue by Region (2017-2022) & (US$ Million)

    Table 10. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Region (2017-2022)

    Table 11. Global Pediatric Epilepsy Therapeutics Revenue by Players (2017-2022) & (US$ Million)

    Table 12. Global Pediatric Epilepsy Therapeutics Market Share by Players (2017-2022)

    Table 13. Global Top Pediatric Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Epilepsy Therapeutics as of 2021)

    Table 14. Ranking of Global Top Pediatric Epilepsy Therapeutics Companies by Revenue (US$ Million) in 2021

    Table 15. Global 5 Largest Players Market Share by Pediatric Epilepsy Therapeutics Revenue (CR5 and HHI) & (2017-2022)

    Table 16. Key Players Headquarters and Area Served

    Table 17. Key Players Pediatric Epilepsy Therapeutics Product Solution and Service

    Table 18. Date of Key Manufacturers Enter into Pediatric Epilepsy Therapeutics Market

    Table 19. Mergers & Acquisitions, Expansion Plans

    Table 20. Global Pediatric Epilepsy Therapeutics Market Size by Type (2017-2022) & (US$ Million)

    Table 21. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2017-2022)

    Table 22. Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 23. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2023-2028)

    Table 24. Global Pediatric Epilepsy Therapeutics Market Size by Application (2017-2022) & (US$ Million)

    Table 25. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2017-2022)

    Table 26. Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 27. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2023-2028)

    Table 28. North America Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 29. North America Pediatric Epilepsy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 30. North America Pediatric Epilepsy Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 31. North America Pediatric Epilepsy Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 32. North America Pediatric Epilepsy Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 33. North America Pediatric Epilepsy Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 34. North America Pediatric Epilepsy Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 35. Europe Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 36. Europe Pediatric Epilepsy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 37. Europe Pediatric Epilepsy Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 38. Europe Pediatric Epilepsy Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 39. Europe Pediatric Epilepsy Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 40. Europe Pediatric Epilepsy Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 41. Europe Pediatric Epilepsy Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 42. Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 43. Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 44. Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 45. Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 46. Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 47. Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Region (2017-2022) & (US$ Million)

    Table 48. Asia Pacific Pediatric Epilepsy Therapeutics Revenue by Region (2023-2028) & (US$ Million)

    Table 49. Latin America Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 50. Latin America Pediatric Epilepsy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 51. Latin America Pediatric Epilepsy Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 52. Latin America Pediatric Epilepsy Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 53. Latin America Pediatric Epilepsy Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 54. Latin America Pediatric Epilepsy Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 55. Latin America Pediatric Epilepsy Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 56. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 57. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 58. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 59. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 60. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 61. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 62. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 63. Abbott Laboratories Company Details

    Table 64. Abbott Laboratories Business Overview

    Table 65. Abbott Laboratories Pediatric Epilepsy Therapeutics Product and Services

    Table 66. Abbott Laboratories Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)

    Table 67. Abbott Laboratories Pediatric Epilepsy Therapeutics SWOT Analysis

    Table 68. Abbott Laboratories Recent Developments

    Table 69. GlaxoSmithKline Company Details

    Table 70. GlaxoSmithKline Business Overview

    Table 71. GlaxoSmithKline Pediatric Epilepsy Therapeutics Product and Services

    Table 72. GlaxoSmithKline Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)

    Table 73. GlaxoSmithKline Pediatric Epilepsy Therapeutics SWOT Analysis

    Table 74. GlaxoSmithKline Recent Developments

    Table 75. Cephalon Company Details

    Table 76. Cephalon Business Overview

    Table 77. Cephalon Pediatric Epilepsy Therapeutics Product and Services

    Table 78. Cephalon Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)

    Table 79. Cephalon Pediatric Epilepsy Therapeutics SWOT Analysis

    Table 80. Cephalon Recent Developments

    Table 81. Pfizer Company Details

    Table 82. Pfizer Business Overview

    Table 83. Pfizer Pediatric Epilepsy Therapeutics Product and Services

    Table 84. Pfizer Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)

    Table 85. Pfizer Pediatric Epilepsy Therapeutics SWOT Analysis

    Table 86. Pfizer Recent Developments

    Table 87. Novartis Company Details

    Table 88. Novartis Business Overview

    Table 89. Novartis Pediatric Epilepsy Therapeutics Product and Services

    Table 90. Novartis Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)

    Table 91. Novartis Pediatric Epilepsy Therapeutics SWOT Analysis

    Table 92. Novartis Recent Developments

    Table 93. Sunovion Pharmaceuticals Company Details

    Table 94. Sunovion Pharmaceuticals Business Overview

    Table 95. Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Product and Services

    Table 96. Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)

    Table 97. Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics SWOT Analysis

    Table 98. Sunovion Pharmaceuticals Recent Developments

    Table 99. Bausch Health Company Details

    Table 100. Bausch Health Business Overview

    Table 101. Bausch Health Pediatric Epilepsy Therapeutics Product and Services

    Table 102. Bausch Health Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)

    Table 103. Bausch Health Pediatric Epilepsy Therapeutics SWOT Analysis

    Table 104. Bausch Health Recent Developments

    Table 105. Sanofi Company Details

    Table 106. Sanofi Business Overview

    Table 107. Sanofi Pediatric Epilepsy Therapeutics Product and Services

    Table 108. Sanofi Pediatric Epilepsy Therapeutics Revenue in Pediatric Epilepsy Therapeutics Business (2017-2022) & (US$ Million)

    Table 109. Sanofi Pediatric Epilepsy Therapeutics SWOT Analysis

    Table 110. Sanofi Recent Developments

    Table 111. Pediatric Epilepsy Therapeutics Market Trends

    Table 112. Pediatric Epilepsy Therapeutics Market Drivers

    Table 113. Pediatric Epilepsy Therapeutics Market Challenges

    Table 114. Pediatric Epilepsy Therapeutics Market Restraints

    Table 115. Research Programs/Design for This Report

    Table 116. Key Data Information from Secondary Sources

    Table 117. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pediatric Epilepsy Therapeutics Sales Market Share by Type: 2021 VS 2028

    Figure 2. Benign Rolandic Epilepsy Features

    Figure 3. Childhood Absence Epilepsy Features

    Figure 4. Juvenile Myoclonic Epilepsy Features

    Figure 5. Infantile Spasms Features

    Figure 6. Lennox-Gastaut Syndrome Features

    Figure 7. Global Pediatric Epilepsy Therapeutics Sales Market Share by Application: 2021 VS 2028

    Figure 8. Hospitals Case Studies

    Figure 9. Neurology Centers Case Studies

    Figure 10. Home Care Settings Case Studies

    Figure 11. Ambulatory Surgical Centers Case Studies

    Figure 12. Pediatric Epilepsy Therapeutics Report Years Considered

    Figure 13. Global Pediatric Epilepsy Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 14. Global Pediatric Epilepsy Therapeutics Market Size 2017-2028 (US$ Million)

    Figure 15. Global Pediatric Epilepsy Therapeutics Market Size Market Share by Region: 2021 VS 2028

    Figure 16. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Region in 2017 VS 2022

    Figure 17. Global Top 10 Pediatric Epilepsy Therapeutics Countries Ranking by Market Size (US$ Million) in 2021

    Figure 18. Global Pediatric Epilepsy Therapeutics Market Share by Players in 2021

    Figure 19. Global Top Pediatric Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Epilepsy Therapeutics as of 2021)

    Figure 20. The Top 10 and 5 Players Market Share by Pediatric Epilepsy Therapeutics Revenue in 2021

    Figure 21. North America Pediatric Epilepsy Therapeutics Revenue Market Share by Company in 2021

    Figure 22. North America Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 23. North America Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 24. North America Pediatric Epilepsy Therapeutics Revenue Share by Country (2017-2028)

    Figure 25. U.S. Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 26. Canada Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 27. Europe Pediatric Epilepsy Therapeutics Revenue Market Share by Company in 2021

    Figure 28. Europe Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 29. Europe Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 30. Europe Pediatric Epilepsy Therapeutics Revenue Share by Country (2017-2028)

    Figure 31. Germany Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 32. France Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 33. U.K. Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 34. Italy Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 35. Russia Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 36. Asia Pacific Pediatric Epilepsy Therapeutics Revenue Market Share by Company in 2021

    Figure 37. Asia Pacific Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 38. Asia Pacific Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 39. Asia Pacific Pediatric Epilepsy Therapeutics Revenue Share by Region (2017-2028)

    Figure 40. China Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 41. Japan Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 42. South Korea Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 43. India Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 44. Australia Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 45. Taiwan Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 46. Indonesia Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 47. Thailand Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 48. Malaysia Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 49. Philippines Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 50. Vietnam Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 51. Latin America Pediatric Epilepsy Therapeutics Revenue Market Share by Company in 2021

    Figure 52. Latin America Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 53. Latin America Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 54. Latin America Pediatric Epilepsy Therapeutics Revenue Share by Country (2017-2028)

    Figure 55. Mexico Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 56. Brazil Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 57. Argentina Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 58. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Market Share by Company in 2021

    Figure 59. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 60. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 61. Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Share by Country (2017-2028)

    Figure 62. Turkey Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 63. Saudi Arabia Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 64. U.A.E Pediatric Epilepsy Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 65. Abbott Laboratories Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)

    Figure 66. GlaxoSmithKline Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)

    Figure 67. Cephalon Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)

    Figure 68. Pfizer Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)

    Figure 69. Novartis Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)

    Figure 70. Sunovion Pharmaceuticals Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)

    Figure 71. Bausch Health Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)

    Figure 72. Sanofi Revenue Growth Rate in Pediatric Epilepsy Therapeutics Business (2017-2022)

    Figure 73. Bottom-up and Top-down Approaches for This Report

    Figure 74. Data Triangulation

    Figure 75. Key Executives Interviewed